Experience of the Administration of First Dose IV Zoledronate at Queen Elizabeth Hospital
{{output}}
Background: Osteoporosis affects nearly 3 million people in the UK, with bisphosphonates forming the mainstay of treatment. While the side effect profile of zoledronate is well-documented, adherence to prescribing guidance and specific population outcomes warr... ...
